Old Web
English
Sign In
Acemap
>
authorDetail
>
Hideo Suzuki
Hideo Suzuki
Pfizer
Adjuvant
Internal medicine
Biochemistry
Antibody titer
Diabetes mellitus
3
Papers
77
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
2017
Current Alzheimer Research
Michael Hüll
Carl Sadowsky
Heii Arai
Ghislaine Le Prince Leterme
Ann Holstein
Kevin Booth
Yahong Peng
Tamotsu Yoshiyama
Hideo Suzuki
Nzeera Ketter
Enchi Liu
J. Michael Ryan
Show All
Source
Cite
Save
Citations (24)
Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies.
2015
Current Alzheimer Research
Heii Arai
Hideo Suzuki
Tamotsu Yoshiyama
Show All
Source
Cite
Save
Citations (40)
Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC-001]) and the QS-21 adjuvant in Japanese individuals with mild-to-moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial
2013
Alzheimers & Dementia
Heii Arai
Hideo Suzuki
Tamotsu Yoshiyama
Kasia Lobello
Yahong Peng
Enchi Liu
Nzeera Ketter
Richard Margolin
Nicholas Jackson
Yoko Fujimoto
Show All
Source
Cite
Save
Citations (13)
1